Marine Natural Products as Anticancer Agents 2.0

doi:10.3390/md21040247

Editorial

. 2023 Apr 17;21(4):247.

doi: 10.3390/md21040247.

Marine Natural Products as Anticancer Agents 2.0

Celso Alves¹, Marc Diederich²

Affiliations

¹ MARE-Marine and Environmental Sciences Centre/ARNET-Aquatic Research Network, ESTM, Polytechnic of Leiria, 2520-630 Peniche, Portugal.
² Department of Pharmacy, College of Pharmacy, Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul 08826, Republic of Korea.

PMID: 37103386
PMCID: PMC10143642
DOI: 10.3390/md21040247

Editorial

Marine Natural Products as Anticancer Agents 2.0

Celso Alves et al. Mar Drugs. 2023.

. 2023 Apr 17;21(4):247.

doi: 10.3390/md21040247.

Authors

Celso Alves¹, Marc Diederich²

Affiliations

¹ MARE-Marine and Environmental Sciences Centre/ARNET-Aquatic Research Network, ESTM, Polytechnic of Leiria, 2520-630 Peniche, Portugal.
² Department of Pharmacy, College of Pharmacy, Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul 08826, Republic of Korea.

PMID: 37103386
PMCID: PMC10143642
DOI: 10.3390/md21040247

Abstract

Global cancer incidence and death are expected to increase to 28 [...].

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

1. Sung H., Ferlay J., Siegel R.L., Laversanne M., Soerjomataram I., Jemal A., Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J. Clin. 2021;71:209–249. doi: 10.3322/caac.21660. - DOI - PubMed
1. Wang N., Ma T., Yu B. Targeting epigenetic regulators to overcome drug resistance in cancers. Signal Transduct. Target. Ther. 2023;8:69. doi: 10.1038/s41392-023-01341-7. - DOI - PMC - PubMed
1. Mayer A.M.S. The Global Marine Pharmaceuticals Pipeline. [(accessed on 5 April 2023)]. Available online: https://www.marinepharmacology.org/about.
1. Li Y., McGowan E., Chen S., Santos J., Yin H., Lin Y. Immunopotentiating Activity of Fucoidans and Relevance to Cancer Immunotherapy. Mar. Drugs. 2023;21:128. doi: 10.3390/md21020128. - DOI - PMC - PubMed
1. Vasarri M., Barletta E., Degl’Innocenti D. Marine Migrastatics: A Comprehensive 2022 Update. Mar. Drugs. 2022;20:273. doi: 10.3390/md20050273. - DOI - PMC - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

Grants and funding

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information

[1] Sung H., Ferlay J., Siegel R.L., Laversanne M., Soerjomataram I., Jemal A., Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J. Clin. 2021;71:209–249. doi: 10.3322/caac.21660. - DOI - PubMed

[2] Sung H., Ferlay J., Siegel R.L., Laversanne M., Soerjomataram I., Jemal A., Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J. Clin. 2021;71:209–249. doi: 10.3322/caac.21660. - DOI - PubMed

[3] Wang N., Ma T., Yu B. Targeting epigenetic regulators to overcome drug resistance in cancers. Signal Transduct. Target. Ther. 2023;8:69. doi: 10.1038/s41392-023-01341-7. - DOI - PMC - PubMed

[4] Wang N., Ma T., Yu B. Targeting epigenetic regulators to overcome drug resistance in cancers. Signal Transduct. Target. Ther. 2023;8:69. doi: 10.1038/s41392-023-01341-7. - DOI - PMC - PubMed

[5] Mayer A.M.S. The Global Marine Pharmaceuticals Pipeline. [(accessed on 5 April 2023)]. Available online: https://www.marinepharmacology.org/about.

[6] Mayer A.M.S. The Global Marine Pharmaceuticals Pipeline. [(accessed on 5 April 2023)]. Available online: https://www.marinepharmacology.org/about.

[7] Li Y., McGowan E., Chen S., Santos J., Yin H., Lin Y. Immunopotentiating Activity of Fucoidans and Relevance to Cancer Immunotherapy. Mar. Drugs. 2023;21:128. doi: 10.3390/md21020128. - DOI - PMC - PubMed

[8] Li Y., McGowan E., Chen S., Santos J., Yin H., Lin Y. Immunopotentiating Activity of Fucoidans and Relevance to Cancer Immunotherapy. Mar. Drugs. 2023;21:128. doi: 10.3390/md21020128. - DOI - PMC - PubMed

[9] Vasarri M., Barletta E., Degl’Innocenti D. Marine Migrastatics: A Comprehensive 2022 Update. Mar. Drugs. 2022;20:273. doi: 10.3390/md20050273. - DOI - PMC - PubMed

[10] Vasarri M., Barletta E., Degl’Innocenti D. Marine Migrastatics: A Comprehensive 2022 Update. Mar. Drugs. 2022;20:273. doi: 10.3390/md20050273. - DOI - PMC - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Marine Natural Products as Anticancer Agents 2.0

Affiliations

Marine Natural Products as Anticancer Agents 2.0

Authors

Affiliations

Abstract

Conflict of interest statement

Similar articles

References

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources

Full Text Sources

Medical